Human testing of the first anti-nicotine vaccine has begun, according to
British drugs company Xenova. Medical director John Roberts says the drug could
help people quit because it prevents nicotine acting on the brain and so stops
addiction. Nicotine patches or gum simply substitute inhaled nicotine with a
more benign form. The vaccine will work best for smokers who risk relapsing
after quitting. The vaccine will stop a lapse of will power “sending you back to
the beginning of the craving cycle”, says Roberts.
To continue reading, today with our introductory offers
Advertisement
More from New Scientist
Explore the latest news, articles and features
Technology
US government wants to have a useful quantum computer by 2028
News
Life
Childbirth for many primate species is even harder than for humans
News
Humans
Humans sleep the least of all apes – is it the secret to our success?
Features
91É«ÇéƬ
Your menstrual cycle may affect how well vaccines work
News
Popular articles
Trending New Scientist articles
1
Where, when and how to watch the 2026 solar eclipse
2
US government wants to have a useful quantum computer by 2028
3
Humans sleep the least of all apes – is it the secret to our success?
4
Our verdict on The Selfish Gene: An unpopular piece of popular science
5
I have a 100 per cent chance of getting cancer due to a rare gene
6
Remote-controlled cockroach swarm can now breathe underwater
7
If you aren't terrified by this heatwave, you should be
8
Fully autonomous drones have killed human soldiers for the first time
9
Woman with Alzheimer's starts conversing again after taking psilocybin
10
Childbirth for many primate species is even harder than for humans
